This could reflect the presence of proliferative prominin-1+ cancer cells or an upregulation of prominin-1 in normal neural stem cells in the vicinity of the tumor at early stages followed by a differentiation of prominin-1+ cancer cells leading to the loss of prominin-1, and consequently a decrease in small prominosomes [171]. This evidence concerns the gene PROM1 and neoplasm.